Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study

por Tsurutani, Junji, Sakata, Yukinori, Matsuoka, Toshiyuki
Publicado 2018

Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan

por NISHIKAWA, Ryo, IWATA, Hisayuki, SAKATA, Yukinori, MURAMOTO, Kenzo, MATSUOKA, Toshiyuki
Publicado 2021

Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study

por Sakata, Yukinori, Matsuoka, Toshiyuki, Ohashi, Satoshi, Koga, Tadashi, Toyoda, Tetsumi, Ishii, Mika
Publicado 2019

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study

por Fukuchi, Yoshinosuke, Tatsumi, Koichiro, Inoue, Hiromasa, Sakata, Yukinori, Shibata, Kai, Miyagishi, Hideaki, Marukawa, Yasuhiro, Ichinose, Masakazu
Publicado 2016

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data

por Kawamura, Takahisa, Kasai, Hidefumi, Fermanelli, Valentina, Takahashi, Toshiaki, Sakata, Yukinori, Matsuoka, Toshiyuki, Ishii, Mika, Tanigawara, Yusuke
Publicado 2018

Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan

por Takahashi, Shunji, Tahara, Makoto, Ito, Koichi, Tori, Masayuki, Kiyota, Naomi, Yoshida, Katsutoshi, Sakata, Yukinori, Yoshida, Akira
Publicado 2020

Impact of the Severity of Alzheimer’s Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications...

por Ashizawa, Takumi, Igarashi, Ataru, Sakata, Yukinori, Azuma, Mie, Fujimoto, Kenichi, Kobayashi, Tsukasa, Takase, Yoshimasa, Ikeda, Shunya
Publicado 2021

Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly

por Igarashi, Ataru, Sakata, Yukinori, Azuma-Kasai, Mie, Kamiyama, Harue, Kawaguchi, Mika, Tomita, Kiyoyuki, Ishii, Mika, Ikeda, Manabu
Publicado 2023

Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting

por Inoue, Kenichi, Takahashi, Masato, Mukai, Hirofumi, Yamanaka, Takashi, Egawa, Chiyomi, Sakata, Yukinori, Ikezawa, Hiroki, Matsuoka, Toshiyuki, Tsurutani, Junji
Publicado 2020

Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan

por Takahashi, Masato, Inoue, Kenichi, Mukai, Hirofumi, Yamanaka, Takashi, Egawa, Chiyomi, Miyoshi, Yasuo, Sakata, Yukinori, Muramoto, Kenzo, Ikezawa, Hiroki, Matsuoka, Toshiyuki, Tsurutani, Junji
Publicado 2021

Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan

por Iuchi, Toshihiko, Inoue, Akihiro, Hirose, Yuichi, Morioka, Motohiro, Horiguchi, Keishi, Natsume, Atsushi, Arakawa, Yoshiki, Iwasaki, Koichi, Fujiki, Minoru, Kumabe, Toshihiro, Sakata, Yukinori
Publicado 2022